fgf8b notes (DANRE, Q805B2)
2026-09-28 session log
- Deep research FAILED for this gene (Edison: 402 Payment Required; the OpenAI key is invalid).
Not retried, per instructions. Literature research was done by hand with Europe PMC REST; the
searches and newly cached PMIDs are listed in ../fgf8a/fgf8a-notes.md.
- Searches for fgf8b (or its old names fgf17 / fgf17a) morphants, mutants or CRISPR alleles found
no published loss-of-function study of fgf8b. Full-text query BODY:"fgf8b morpholino" OR ...
returned 0 hits; BODY:"fgf8b mutant" hits are dominated by the unrelated human FGF8b SPLICE
ISOFORM. So every functional claim for fgf8b is expression, gain of function, or inference.
Identity and naming
- Originally described as zebrafish fgf17 (Reifers et al. 2000); UniProt synonyms fgf17, fgf17a
[file:DANRE/fgf8b/fgf8b-uniprot.txt "Synonyms=fgf17"].
- Renamed as a TGD co-orthologue of FGF8
PMID:17708537.
- Even at first description it was closer to Fgf8 in sequence
PMID:11091072.
- Synteny: fgf8b on Dre1 with FGF8-flanking orthologues
PMID:19562753.
- The fgf8b block lost fbxw4, whose introns carry fgf8 enhancers
PMID:17387144.
- Protein: 212 aa, signal peptide 1-27, one N-glycosylation site; 70.8% identity to fgf8a
(compare_pair.py). UniProt protein existence is "Evidence at transcript level".
Expression (UniProt / PMID:11091072 and PMID:19562753)
- Not expressed during gastrulation; first at 8 somites in ventral MHB and anterior somites;
optic stalks; otic vesicle at 24 h; hyoid at 30 h; dorsal diencephalon at 36 h
[file:DANRE/fgf8b/fgf8b-uniprot.txt "Not expressed during gastrulation."].
- Shared with fgf8a at mid-somitogenesis: MHB and somites
PMID:19562753.
- fgf8a-only domains: dorsal diencephalon and tailbud at mid-segmentation; telencephalon,
olfactory epithelium, pharyngeal arches and fin AER at long-pec; heart.
PMID:19562753
- Ear, anterior sensory patch: zebrafish fgf8b weak, fgf8a strong; stickleback the reverse
PMID:19562753.
- No fgf8b-unique expression domain in zebrafish is reported in the sources read.
Function
- Protein activity: mRNA injection shows it can act like fgf8
PMID:11091072.
- Regulation: downstream of pax2a (dose-dependent) and of fgf8a (maintenance) at the MHB
PMID:11091072.
- Redundancy with fgf8a: the only test (ace;noi double mutants lacking fgf8a function and fgf8b
expression) showed no enhanced DA-neuron phenotype
PMID:12843251.
Decisions
- 20 GOA rows reviewed.
- MF (growth factor activity, FGFR1/FGFR2 binding, FGFR binding NAS), FGFR signalling, MAPK
cascade and extracellular region: ACCEPT. The protein keeps the FGF8 fold and signal peptide and
acts like fgf8 in an injection assay, so the IBA MF/pathway terms apply to both paralogues.
- Cytoplasm IBA: MARK_AS_OVER_ANNOTATED (secreted ligand), same as fgf8a and human FGF8.
- D/V pattern formation IBA: MARK_AS_OVER_ANNOTATED. The protein could act in D/V patterning
(injection assay), but the D/V axis is set in the blastula/gastrula, when fgf8b is not expressed.
This is an expression-level loss of an ancestral subfunction, not a protein-level one.
- ARBA negative regulation of endodermal cell fate specification: REMOVE (gastrula-stage process;
fgf8b not expressed then; no fgf8b evidence).
- ARBA mesoderm development and A/P pattern specification: MARK_AS_OVER_ANNOTATED (no
fgf8b-specific evidence; the fgf8a evidence is gastrula-stage).
- NAS MHB development and pattern specification process: KEEP_AS_NON_CORE (expression and
genetic-hierarchy evidence only; no loss-of-function).
- No NEW terms: no loss-of-function data exist for fgf8b.